Literature DB >> 10759156

Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency.

M Kishikawa1, T Nakanishi, A Shimizu, M Yoshino.   

Abstract

Serum transthyretin has several isoforms, most of which are caused by disulfide linkage with cysteine residue at position 10. We found an ion peak 80 D larger than unmodified transthyretin by electrospray ionization mass spectrometry and assigned it to S-sulfonated transthyretin. The peak height was <2% of total transthyretin in control sera from more than 200 individuals including infants. Transthyretin from a patient with molybdenum cofactor deficiency was analyzed, and the peak was prominent, higher than 85% of total transthyretin. In patients with this disease, the presence of elevated levels of sulfite leads to the formation of S-sulfonated cysteine. The peak can be used as a diagnostic marker for molybdenum cofactor deficiency, although more sera from patients with this disease should be tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759156     DOI: 10.1203/00006450-200004000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Hypohomocysteinaemia and highly increased proportion of S-sulfonated plasma transthyretin in molybdenum cofactor deficiency.

Authors:  J O Sass; M Kishikawa; R Puttinger; J Reiss; W Erwa; A Shimizu; W Sperl
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation.

Authors:  Melissa H Y Chang; Chi T Hua; Elizabeth L Isaac; Tom Litjens; Greg Hodge; Litsa E Karageorgos; Peter J Meikle
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

3.  High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Authors:  Stephen Barnes; Erin M Shonsey; Shannon M Eliuk; David Stella; Kerri Barrett; Om P Srivastava; Helen Kim; Matthew B Renfrow
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.